Company news
Actinogen Medical Limited news in 2026
Actinogen Medical Limited's news releases, calls and decks from 2026, newest first.
ACW Bioshares presentation, strong cortisol rationale
August 5, 2026
Application for quotation of securities - ACW
August 4, 2026
ACW webinar on the future of Alzheimers treatment
August 4, 2026
June 2026 Quarterly activity report & Appendix 4C
July 29, 2026
Application for quotation of securities - ACW
July 28, 2026
Xanamem depression trial published in British J Psychiatry
July 19, 2026
ACW third positive XanaMIA trial data committee review
June 17, 2026
Actinogen receives positive EMA scientific advice aligned with prior FDA guidance for its Alzheimer’s disease program
May 28, 2026
Actinogen receives positive scientific advice from EMA
May 27, 2026
Correction-March2026 quarterly activity report & Appendix 4C
April 28, 2026
Actinogen commences open-label phase of XanaMIA Alzheimer’s trial and provides business update
April 1, 2026
ACW XanaMIA Alzheimers open label trial commences
March 31, 2026
ACW successfully completes $16.8m Placement and SPP
February 26, 2026
ACW HY26 results - XanaMIA pivotal Alzheimers trial progress
February 25, 2026
Actinogen HY2025 financial report and Appendix 4D
February 25, 2026
ACW receives further $1.9m FY2025 R&D rebate from ATO
February 10, 2026
Actinogen receives positive Interim Analysis recommendation from its independent Data Monitoring Committee to continue the XanaMIA pivotal Alzheimer’s disease trial
February 2, 2026
ACW secures funding beyond XanaMIA AD trial final results
February 1, 2026
ACW December 2025 quarterly activity report & Appendix 4C
January 29, 2026
Continuation of Trading Halt
January 29, 2026
ACW positive XanaMIA Interim Analysis outcome
January 29, 2026
Trading Halt
January 28, 2026
Actinogen secures $4.3m of non-dilutive R&D tax funding
January 26, 2026
Decks in 2026
- Technical Presentation (November 2026)
Technical · 19 slides · Nov 19, 2026
- Investor Presentation (October 2026)
Investor deck · 30 slides · October 2026
- 6th International Conference on Cognitive and Behavioral Neurosciences (September 2026)
Conference · 26 slides · Sep 9, 2026
- Bioshares Biotech Summit 2026
Conference · 17 slides · Aug 6, 2026
- Alzheimer's Association International Conference (AAIC) 2026
Conference · 37 slides · Jul 8, 2026
- Investor Presentation (May 2026)
Investor deck · 29 slides · May 1, 2026
- Investor Presentation (March 2026)
Investor deck · 29 slides · March 2026
- Investor Presentation (February 2026)
Investor deck · 25 slides · Feb 2, 2026
- Investor Presentation (January 2026)
Investor deck · 23 slides · January 2026